ArticleThe Journal of clinical investigation2023
Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinoma.
Mingen Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
43 papers cite it
this paperpooled itcites it